Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

BACKGROUND: Allogeneic hematopoietic cell transplantation is considered the preferred post-remission therapy in patients with acute myeloid leukemia cytogenetically defined as being at high risk. To substantiate evidence for allogeneic hematopoietic cell transplantation in first complete remission i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stelljes, Matthias, Beelen, Dietrich W., Braess, Jan, Sauerland, Maria C., Heinecke, Achim, Berning, Björna, Kolb, Hans J., Holler, Ernst, Schwerdtfeger, Rainer, Arnold, Renate, Spiekermann, Karsten, Müller-Tidow, Carsten, Serve, Hubert L., Silling, Gerda, Hiddemann, Wolfgang, Berdel, Wolfgang E., Büchner, Thomas, Kienast, Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3128215/
https://ncbi.nlm.nih.gov/pubmed/21459795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.041004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados